Postoperative radiation therapy after hip replacement in high-risk patients for development of heterotopic bone formation

Cancer/Radiotherapie

Volumn 15, Issue 4, 2011, Pages 261-264

  Hashem, R ^a   Tanzer, M ^a   Rene, N ^a   Evans, M ^a   Souhami, L ^a  

^a MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

Benign disease; Heterotopic bone formation; Hip replacement; Radiation therapy

Indexed keywords

ADULT; AGED; ANKYLOSING SPONDYLITIS; ARTICLE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; FEMALE; FOLLOW UP; HETEROTOPIC OSSIFICATION; HIGH RISK PATIENT; HIP ARTHROPLASTY; HUMAN; MALE; OSTEOARTHRITIS; PREOPERATIVE RADIOTHERAPY; PRIORITY JOURNAL; RADIATION DOSE; TREATMENT DURATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARTHROPLASTY, REPLACEMENT, HIP; BONE AND BONES; CHORISTOMA; FEMALE; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE CARE; RADIOTHERAPY; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 79960070905     PISSN: 12783218     EISSN: 17696658     Source Type: Journal    
DOI: 10.1016/j.canrad.2010.10.003     Document Type: Article

References (23)

1. Ritter M.A., Vaughan R.B. Ectopic ossification after total hip arthroplasty. Predisposing factors, frequency, and effect on results. J Bone Joint Surg Am 1977, 59:345-351.
2. Eggli S., Woo A. Risk factors for heterotopic ossification in total hip arthroplasty. Arch Orthop Trauma Surg 2001, 121:531-535.
3. MacLennan I., Keys H.M., Evarts C.M., Rubin P. Usefulness of postoperative hip irradiation in the prevention of heterotopic bone formation in a high-risk group of patients. Int J Radiat Oncol Biol Phys 1984, 10:49-53.
4. Healy W.L., Lo T.C., Covall D.J., Pfeifer B.A., Wasilewski S.A. Single-dose radiation therapy for prevention of heterotopic ossification after total hip arthroplasty. J Arthroplasty 1990, 5:369-375.
5. Lo T.C. Radiation therapy for heterotopic ossification. Semin Radiat Oncol 1999, 9:163-170.
6. Padgett D.E., Holley K.G., Cummings M., Rosenberg A.G., Sumner D.R., Conterato D., et al. The efficacy of 500 cGy radiation in the prevention of heterotopic ossification after total hip arthroplasty: a prospective, randomized, pilot study. J Arthroplasty 2003, 18:677-686.
7. Neal B., Gray H., MacMahon S., Dunn L. Incidence of heterotopic bone formation after major hip surgery. ANZ J Surg 2002, 72:808-821.
8. Brooker A.F., Bowerman J.W., Robinson R.A., Riley L.H. Ectopic ossification following total hip replacement. Incidence and a method of classification. J Bone Joint Surg Am 1973, 55:1629-1632.
9. Buschbacher R., McKinley W., Buschbacher L., Devaney C.W., Coplin B. Warfarin in prevention of heterotopic ossification. Am J Phys Med Rehabil 1992, 71:86-91.
10. Biering-Sorensen F., Tondevold E. Indomethacin and disodium etidronate for the prevention of recurrence of heterotopic ossification after surgical resection. Two case reports. Paraplegia 1993, 31:513-515.
11. Moed B.R., Karges D.E. Prophylactic indomethacin for the prevention of heterotopic ossification after acetabular fracture surgery in high-risk patients. J Orthop Trauma 1994, 8:34-39.
12. Vavken P., Castellani L., Sculco T.P. Prophylaxis of heterotopic ossification of the hip: systematic review and meta-analysis. Clin Orthop Relat Res 2009, 467:3283-3289.
13. Fingeroth R.J., Ahmed A.Q. Single dose 6 Gy prophylaxis for heterotopic ossification after total hip arthroplasty. Clin Orthop Relat Res 1995, 317:131-140.
14. Childs H.A., Cole T., Falkenberg E., Smith J.T., Alonso J.E., et al. A prospective evaluation of the timing of postoperative radiotherapy for preventing heterotopic ossification following traumatic acetabular fractures. Int J Radiat Oncol Biol Phys 2000, 47:1347-1352.
15. Kennedy W.F., Gruen T.A., Chessin H., Gasparini G., Thompson W. Radiation therapy to prevent heterotopic ossification after cementless total hip arthroplasty. Clin Orthop Relat Res 1991, 262:185-191.
16. Konski A., Pellegrini V., Poulter C., DeVanny J., Rosier R., Evarts C.M., et al. Randomized trial comparing single dose versus fractionated irradiation for prevention of heterotopic bone: a preliminary report. Int J Radiat Oncol Biol Phys 1990, 18:1139-1142.
17. Seegenschmiedt M.H., Keilholz L., Martus P., Goldmann A., Wölfel R., Henning F., et al. Prevention of heterotopic ossification about the hip: final results of two randomized trials in 410 patients using either preoperative or postoperative radiation therapy. Int J Radiat Oncol Biol Phys 1997, 39:161-171.
18. Healy W.L., Lo T.C., DeSimone A.A., Rask B., Pfeifer B.A. Single-dose irradiation for the prevention of heterotopic ossification after total hip arthroplasty. A comparison of doses of five hundred and fifty and seven hundred centigray. J Bone Joint Surg Am 1995, 77:590-595.
19. Evans M.D., Patrocinio H.J., Souhami L., Tanzer M., Podgorsak E.B. Dosimetry of hip irradiation for the prevention of heterotopic bone formation after arthroplasty. Int J Radiat Oncol Biol Phys 1999, 43:1161-1165.
20. Sylvester J.E., Blount L.H., Selch M.T. Technical considerations in the use of prophylactic radiation therapy to prevent heterotopic bone formation. Semin Arthroplasty 1992, 3:167-171.
21. DeFlitch C.J., Stryker J.A. Postoperative hip irradiation in prevention of heterotopic ossification: causes of treatment failure. Radiology 1993, 188:265-270.
22. Sargos P., Mamou N., Dejean C., Figueiredo B.H., Huchet A., Italiano A., et al. Dose de tolérance à l'irradiation des tissus sains: l'os chez l'adulte. Cancer Radiother 2010, 14:386-391.
23. Tubiana M. La prévention du cancer et la relation dose-effet: l'effet cancérogène des radiations ionisantes. Cancer Radiother 2009, 13:238-258.